← Open Payments lookup

KEMAYA WILBURN: Open Payments

NPI 1841675667 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$229 in 8 payments from 5 companies in 2025. Trend: 2023 $544 · 2024 $167 · 2025 $229

Food & beverage: $229
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.1$81
E.R. Squibb & Sons, L.L.C.3$61
Teva Pharmaceuticals USA, Inc.2$45
Alkermes, Inc.1$21
Vanda Pharmaceuticals Inc.1$20

Products named: INGREZZA, COBENFY, UZEDY, ARISTADA, FANAPT.

Industry payments across GA — which companies pay providers there.